NCT04904497

Brief Summary

This study evaluates the feasibility of an early occupational therapy (OT) protocol in critical adult patients requiring mechanical ventilation with Covid-19.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
60

participants targeted

Target at P25-P50 for not_applicable covid19

Timeline
Completed

Started Apr 2021

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2021

Completed
29 days until next milestone

First Submitted

Initial submission to the registry

April 30, 2021

Completed
27 days until next milestone

First Posted

Study publicly available on registry

May 27, 2021

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2021

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2021

Completed
Last Updated

May 27, 2021

Status Verified

May 1, 2021

Enrollment Period

8 months

First QC Date

April 30, 2021

Last Update Submit

May 26, 2021

Conditions

Outcome Measures

Primary Outcomes (1)

  • Functional independence at hospital discharge

    The FIM (Functional independence measure) instrument will be applied by evaluator team. This scale shows that higher score is better, which will be compared between control and experimental group

    Day 28 (+/- 3 days) from beginning of mechanical ventilation

Secondary Outcomes (8)

  • Delirium-free days

    Defined as the number of days in the first 14 days with the CAM-ICU instrument negative and non-coma day.

  • Coma-free days

    Defined as the number of days in the first 14 days with the SAS.

  • Delirium-coma free days

    Defined as the number of days in the first 14 days with the SAS and CAM-ICU

  • Functional independence at hospital discharge

    Day 90 (+/- 7 days) from beginning of mechanical ventilation

  • Cognitive status of patients

    Day 28 (+/- 3 days) from beginning of mechanical ventilation and day 90 (+/- 7 days)after hospital discharge

  • +3 more secondary outcomes

Study Arms (2)

Early Occupational Therapy

EXPERIMENTAL

These sessions will be implemented by occupational therapists trained in ICU, who will conduct 20 sessions of 30 min, distributed depending on the level of sedation, i) SAS (Sedation-Agitation Scale) 1 patients have one session each 48 h, evaluating the change of sedation level each 24 h; ii) SAS 2 patients have one session each 24 h, iii) SAS 3-5 have two sessions every day. The sessions will begin once the patient needs mechanical ventilation for at least 12 h

Behavioral: Early Occupational Therapy

Standard

NO INTERVENTION

The ASDM protocol will be implemented to mechanically ventilated patients in the ICU, following the aspects recommended by experts and the current evidence. For this, the team of medical, nurses, and physiotherapist will be trained to understand and facilitate the ASDM actions that each one must implement. Occupational Therapy interventions for control group will be allowed for this group only before 1 week after the first day on light sedation

Interventions

Occupational therapists will implement the following activities: * Polysensory stimulation: external stimulation for increasing the level of alertness. It will be implemented with SAS 2 one session each 24 h. * Cognitive stimulation: bundle of exercises for activating mental functions, i.e: alertness, visual perception, memory, calculus, problem solving, praxis, language. Patients with SAS 3, 4 and 5. In SAS \<2, 6\> environmental orientation will be considered * Basic activities of daily living (BADLs): promotion of independence that initially practice hygiene, personal grooming. Patients with SAS 3, 4 and 5 * Motor function Stimulation: exercises to keep the patient's upper extremities active and functional. Patients with SAS with 3,4 and 5. Patients with SAS 1 and 2 will use adaptations to prevent edema and bedsores on vulnerable body areas * Education: trained family members and health staff about the intervention process

Early Occupational Therapy

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age equal to or greater than 18 years.
  • Need for hospitalization in ICU.
  • At least 12 h of invasive mechanical ventilation
  • Informed consent signed by legal representative and / or patient.
  • Positive covid-19 diagnosis

You may not qualify if:

  • Known cognitive impairment before admission with short IQCODE (Informant Questionnaire on Cognitive Decline in the Elderly) Scores\> 3.3 were excluded.
  • Previous functional impairment, FAQ (Functional Activities Questionnaire) defined as \> 6 points.
  • Severe communication disorder and cultural limitation of language (language different from Spanish)
  • Patient with limited therapeutic proportionality.
  • Neurocritical patients (moderate-severe Traumatic Brain Injury / stroke of some kind / among others)
  • Spinal injury or unstable fractures that limit mobilization

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Chile

Santiago, Santiago Metropolitan, Chile

RECRUITING

MeSH Terms

Conditions

COVID-19Critical IllnessCognitive DysfunctionAtaxia

Condition Hierarchy (Ancestors)

Pneumonia, ViralPneumoniaRespiratory Tract InfectionsInfectionsVirus DiseasesCoronavirus InfectionsCoronaviridae InfectionsNidovirales InfectionsRNA Virus InfectionsLung DiseasesRespiratory Tract DiseasesDisease AttributesPathologic ProcessesPathological Conditions, Signs and SymptomsCognition DisordersNeurocognitive DisordersMental DisordersDyskinesiasNeurologic ManifestationsNervous System DiseasesSigns and Symptoms

Central Study Contacts

Eduardo Tobar, MD

CONTACT

Evelyn Alvarez, Master

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Masking Details
In this study, researchers, recruiters, evaluators, control group team and data analyst will be masked. These teams will not have contact with the interventionists of the experimental group. Evaluators who have contact with the patients of both groups, they will be professionals from other medical units, who do not know the ICU team, and will only be able to maintain their dialog, according to the guideline of each evaluation. It is not possible to mask the treating occupational therapist and patient receiving OT.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: A control group (standard ASDM measures) or an intervention group (early and intensive occupational therapy + ASDM) will be randomized. The intervention group will receive 20 occupational therapy sessions. The interventions will be organized on the basis of i) level of sedation, ii) presence or absence of delirium (according to CAM ICU +/- (Confusion Assessment Method Intensive Care Unit)), iii) movement with or without gravity (cut-off point 3 points in elbow flexion movement in Medical Research Council(MRC)). The areas of intervention implemented by occupational therapist will be: i) Polysensory stimulation, ii) Cognitive stimulation, iii) Basic activities of daily living, iv) Motor function stimulation, v) Education
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associated professor

Study Record Dates

First Submitted

April 30, 2021

First Posted

May 27, 2021

Study Start

April 1, 2021

Primary Completion

December 1, 2021

Study Completion

December 31, 2021

Last Updated

May 27, 2021

Record last verified: 2021-05

Data Sharing

IPD Sharing
Will not share

Locations